Research Article| Volume 58, ISSUE 12, P1737-1742, December 2009

Download started.


Obesity and metabolic syndrome–related chronic kidney disease in nondiabetic, nonhypertensive adults


      Metabolic syndrome (MS) is associated with chronic kidney disease (CKD). The objective of this study is to examine the association between obesity and MS-related CKD in nondiabetic, nonhypertensive Korean adults. Korea National Health and Nutrition Examination Survey III data from 3771 nondiabetic, nonhypertensive Koreans were analyzed. Metabolic syndrome was defined according to the National Cholesterol Education Program–Adult Treatment Panel III, and CKD was diagnosed at an estimated glomerular filtration rate less than 60 mL/(min 1.73m2). The crude and multivariate-adjusted odds ratios (ORs) of CKD associated with MS and its individual components were calculated using logistic regression models in a study population stratified by obesity. The prevalence of MS and CKD was 13.4% and 3.2%, respectively. The association between MS and CKD was significant in obese (OR, 2.91; 95% confidence interval [CI] = 1.34-6.34), but not nonobese (OR, 1.38; 95% CI = 0.60-3.17), subjects. In obese subjects, impaired fasting glucose (OR, 2.47; 95% CI = 1.10-5.57) and high triglyceride levels (OR, 2.42; 95% CI = 1.01-5.83) were risk factors for CKD, whereas no components were significantly associated with CKD in nonobese subjects. Our findings suggest that even in nondiabetic, nonhypertensive Korean adults, early detection and prevention of CKD in obese subjects with MS are critical.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • McCulloch C.E.
        • Hsu C.Y.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Kiberd B.
        The chronic kidney disease epidemic: stepping back and looking forward.
        J Am Soc Nephrol. 2006; 17: 2967-2973
        • Weiner D.E.
        • Tighiouart H.
        • Amin M.G.
        • Stark P.C.
        • MacLeod B.
        • Griffith J.L.
        Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
        J Am Soc Nephrol. 2004; 15: 1307-1315
        • Fox C.S.
        • Larson M.G.
        • Leip E.P.
        • Culleton B.
        • Wilson P.W.
        • Levy D.
        Predictors of new-onset kidney disease in a community-based population.
        JAMA. 2004; 291: 844-850
        • Ejerblad E.
        • Fored C.M.
        • Lindblad P.
        • Fryzek J.
        • McLaughlin J.K.
        • Nyren O.
        Obesity and risk for chronic renal failure.
        J Am Soc Nephrol. 2006; 17: 1695-1702
        • Hsu C.Y.
        • McCulloch C.E.
        • Iribarren C.
        • Darbinian J.
        • Go A.S.
        Body mass index and risk for end-stage renal disease.
        Ann Intern Med. 2006; 144: 21-28
        • Iseki K.
        • Ikemiya Y.
        • Kinjo K.
        • Inoue T.
        • Iseki C.
        • Takishita S.
        Body mass index and the risk of development of end-stage renal disease in a screened cohort.
        Kidney Int. 2004; 65: 1870-1876
        • Chen J.
        • Gu D.
        • Chen C.S.
        • Wu X.
        • Hamm L.L.
        • Muntner P.
        Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
        Nephrol Dial Transplant. 2007; 22: 1100-1106
        • Chen J.
        • Muntner P.
        • Hamm L.L.
        • Jones D.W.
        • Batuman V.
        • Fonseca V.
        The metabolic syndrome and chronic kidney disease in U.S. adults.
        Ann Intern Med. 2004; 140: 167-174
        • Tozawa M.
        • Iseki C.
        • Tokashiki K.
        • Chinen S.
        • Kohagura K.
        • Kinjo K.
        Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
        Hypertens Res. 2007; 30: 937-943
        • Zhang L.
        • Zuo L.
        • Wang F.
        • Wang M.
        • Wang S.
        • Liu L.
        Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older.
        Mayo Clin Proc. 2007; 82: 822-827
        • Kitiyakara C.
        • Yamwong S.
        • Cheepudomwit S.
        • Domrongkitchaiporn S.
        • Unkurapinun N.
        • Pakpeankitvatana V.
        The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort.
        Kidney Int. 2007; 71: 693-700
        • Kurella M.
        • Lo J.C.
        • Chertow G.M.
        Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
        J Am Soc Nephrol. 2005; 16: 2134-2140
        • Rashidi A.
        • Ghanbarian A.
        • Azizi F.
        Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population.
        Clin J Am Soc Nephrol. 2007; 2: 976-983
        • Kanauchi M.
        • Kanauchi K.
        • Kimura K.
        • Inoue T.
        • Saito Y.
        Associations of chronic kidney disease with the metabolic syndrome in non-diabetic elderly.
        Nephrol Dial Transplant. 2006; 21: 3608-3609
        • Lee J.E.
        • Choi S.Y.
        • Huh W.
        • Kim Y.G.
        • Kim D.J.
        • Oh H.Y.
        Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
        Am J Hypertens. 2007; 20: 1189-1194
        • Sedor J.R.
        • Schelling J.R.
        Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: the fat lady sings.
        J Am Soc Nephrol. 2005; 16: 1880-1882
        • Stengel B.
        • Jaussent I.
        • Guiserix J.
        • Bourgeon B.
        • Papoz L.
        • Favier F.
        High prevalence of chronic kidney disease in La Reunion island and its association with the metabolic syndrome in the non-diabetic population: La Reunion Diabetes (REDIA) Study.
        Diabetes Metab. 2007; 33: 444-452
        • Gatti A.
        • Morini E.
        • Cosmo S.D.
        • Maiani F.
        • Mandosi E.
        • Fallarino M.
        Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
        Obesity. 2008; 16: 899-901
        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • Donato K.A.
        • Eckel R.H.
        • Franklin B.A.
        Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
        Circulation. 2005; 112: 2735-2752
        • World. Health Organization Western Pacific Region
        International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment.
        Health Communications Australia Pty Limited, Sydney2000
        • Levey A.S.
        • Bosch J.P.
        • Lewis J.B.
        • Greene T.
        • Rogers N.
        • Roth D.
        A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
        Ann Intern Med. 1999; 130: 461-470
        • Chagnac A.
        • Weinstein T.
        • Korzets A.
        • Ramadan E.
        • Hirsch J.
        • Gafter U.
        Glomerular hemodynamics in severe obesity.
        Am J Physiol Renal Physiol. 2000; 278: F817-F822
        • Chang C.J.
        • Wu C.H.
        • Chang C.S.
        • Yao W.J.
        • Yang Y.C.
        • Wu J.S.
        Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs.
        Int J Obes Relat Metab Disord. 2003; 27: 253-259
        • Deurenberg P.
        • Deurenberg-Yap M.
        • Guricci S.
        Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship.
        Obes Rev. 2002; 3: 141-146
        • Dhiman R.K.
        • Duseja A.
        • Chawla Y.
        Asians need different criteria for defining overweight and obesity.
        Arch Intern Med. 2005; 165: 1069-1070
        • Korean. Ministry of Health and Welfare
        The Korean National Health Nutrition Examination Survey 2005.
        Korean Ministry of Health and Welfare, Seoul2006
        • Kamijo A.
        • Kimura K.
        • Sugaya T.
        • Yamanouchi M.
        • Hase H.
        • Kaneko T.
        Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage.
        Kidney Int. 2002; 62: 1628-1637
        • Wisse B.E.
        The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
        J Am Soc Nephrol. 2004; 15: 2792-2800
        • Bavbek N.
        • Isik B.
        • Kargili A.
        • Uz E.
        • Uz B.
        • Kanbay M.
        • et al.
        Association of obesity with inflammation in occult chronic kidney disease.
        J Nephrol. 2008; 21: 761-767
        • Ramkumar N.
        • Cheung A.K.
        • Pappas L.M.
        • Roberts W.L.
        • Beddhu S.
        Association of obesity with inflammation in chronic kidney disease: a cross sectional study.
        J Ren Nutr. 2004; 14: 201-207
        • Abrass C.K.
        • Raugi G.J.
        • Gabourel L.S.
        • Lovett D.H.
        Insulin and insulin-like growth factor I binding to cultured rat glomerular mesangial cells.
        Endocrinology. 1988; 123: 2432-2439
        • Cusumano A.M.
        • Bodkin N.L.
        • Hansen B.C.
        • Iotti R.
        • Owens J.
        • Klotman P.E.
        Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys.
        Am J Kidney Dis. 2002; 40: 1075-1085
        • Chen J.
        • Muntner P.
        • Hamm L.L.
        • Fonseca V.
        • Batuman V.
        • Whelton P.K.
        Insulin resistance and risk of chronic kidney disease in nondiabetic US adults.
        J Am Soc Nephrol. 2003; 14: 469-477
        • Fried L.F.
        • Orchard T.J.
        • Kasiske B.L.
        Effect of lipid reduction on the progression of renal disease: a meta-analysis.
        Kidney Int. 2001; 59: 260-269
        • Kasiske B.L.
        • O'Donnell M.P.
        • Cleary M.P.
        • Keane W.F.
        Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
        Kidney Int. 1988; 33: 667-672